-
1.[1,2,4]OXADIAZOL-3-YL ACID SALTS AND CRYSTALLINE FORMS AND THEIR PREPARATION 审中-公开
Title translation: [1,2,4] OXADIAZOL-3-YL酸盐和晶体形态及其制备公开(公告)号:WO2012112841A3
公开(公告)日:2013-03-14
申请号:PCT/US2012025570
申请日:2012-02-17
Applicant: ABBOTT LAB , ZHANG GEOFF G , BRACKEMEYER PAUL J , CHEN SHAUNG , GORDON THOMAS D
Inventor: ZHANG GEOFF G , BRACKEMEYER PAUL J , CHEN SHAUNG , GORDON THOMAS D
CPC classification number: C07D413/04 , A61K31/4245 , A61K31/4439 , C07D271/06
Abstract: The present invention relates to salts and crystalline forms of [1,2,4]oxadiazol-3-yl]-phenoxy}-cycloalkyl carboxylic acids, processes for their preparation, pharmaceutical compositions comprising such compounds, and methods of using them.
Abstract translation: 本发明涉及[1,2,4]恶二唑-3-基] - 苯氧基} - 环烷基羧酸的盐和结晶形式,其制备方法,包含这些化合物的药物组合物及其使用方法。
-
公开(公告)号:WO2005110410A3
公开(公告)日:2007-03-29
申请号:PCT/US2005016903
申请日:2005-05-13
Applicant: ABBOTT LAB , CUSACK KEVIN , SALMERON-GARCIA JOSE-ANDRES , GORDON THOMAS D , BARBERIS CLAUDE E , ALLEN HAMISH J , BISCHOFF AGNIESZKA K , ERICSSON ANNA M , FRIEDMAN MICHAEL M , GEORGE DAWN M , ROTH GREGORY P , TALANIAN ROBERT V , THOMAS CHRISTINE , WALLACE GRIER A , WISHART NEIL , YU ZHENGTIAN
Inventor: CUSACK KEVIN , SALMERON-GARCIA JOSE-ANDRES , GORDON THOMAS D , BARBERIS CLAUDE E , ALLEN HAMISH J , BISCHOFF AGNIESZKA K , ERICSSON ANNA M , FRIEDMAN MICHAEL M , GEORGE DAWN M , ROTH GREGORY P , TALANIAN ROBERT V , THOMAS CHRISTINE , WALLACE GRIER A , WISHART NEIL , YU ZHENGTIAN
IPC: C07D471/02 , A61K31/4743 , C07D471/04 , C07D491/04 , C07D495/04 , C07D498/02
CPC classification number: C07D471/04 , A61K31/4743 , C07D487/04 , C07D491/04 , C07D495/04
Abstract: A compound or pharmaceutically acceptable salts thereof of Formula (I) wherein the substituents are as defined herein, which are useful as kinase inhibitors.
Abstract translation: 式(I)的化合物或其药学上可接受的盐,其中取代基如本文所定义,其可用作激酶抑制剂。
-
公开(公告)号:EP2001480A4
公开(公告)日:2011-06-15
申请号:EP07754773
申请日:2007-04-02
Applicant: ABBOTT LAB
Inventor: ERICSSON ANNA M , BURCHAT ANDREW , FRANK KRISTINE E , CALDERWOOD DAVID J , ABBOTT LILY K , ARGIRIADI MARIA A , BORHANI DAVID W , CUSACK KEVIN P , DIXON RICHARD W , GORDON THOMAS D , MULLEN KELLY D , TALANIAN ROBERT V , WU XIAOYUN , ZHANG XIAOLEI , WANG LU X , LI BIQIN , BARBERIS CLAUDE E , WISHART NEIL
IPC: A61K31/196 , A61P35/00 , C07D403/12
CPC classification number: C07D487/04 , C07D403/12 , C07D403/14 , C07D409/04 , C07D409/14
-
4.SPHINGOSINE-1 -PHOSPHATE RECEPTOR AGONIST AND ANTAGONIST COMPOUNDS 审中-公开
Title translation: SPHINGOSINE 1磷酸受体激动剂和拮抗剂化合物公开(公告)号:EP2120575A4
公开(公告)日:2011-04-27
申请号:EP07863237
申请日:2007-12-21
Applicant: ABBOTT LAB
Inventor: WALLACE GRIER A , BREINLINGER ERIC C , CUSACK KEVIN P , FIX-STENZEL SHANNON R , GORDON THOMAS D , HOBSON ADRIAN D , HAYES MARTIN E , ANSELL GRAHAM K , GRONGSAARD PINTIPA
IPC: A01N43/50 , A61K31/415 , A61P25/28 , C07C215/38 , C07C215/42 , C07C217/74 , C07C229/14 , C07C229/48 , C07D205/04 , C07D207/12 , C07D207/14 , C07D213/30 , C07D263/32 , C07D263/52 , C07D271/06 , C07D307/22 , C07D307/24 , C07D333/16 , C07D413/04 , C07F9/30 , C07F9/38 , C07F9/40 , C07F9/653 , C07F9/655 , C07F9/6553
CPC classification number: C07D413/04 , C07C215/38 , C07C215/42 , C07C217/52 , C07C217/74 , C07C229/14 , C07C229/48 , C07C2601/02 , C07C2601/08 , C07D205/04 , C07D207/12 , C07D207/14 , C07D213/30 , C07D263/32 , C07D263/52 , C07D271/06 , C07D307/22 , C07D307/24 , C07D333/16 , C07D491/107 , C07F9/091 , C07F9/301 , C07F9/3808 , C07F9/3826 , C07F9/4006 , C07F9/653 , C07F9/65515 , C07F9/655345
-
公开(公告)号:WO2009011850A2
公开(公告)日:2009-01-22
申请号:PCT/US2008008645
申请日:2008-07-15
Applicant: ABBOTT LAB , BREINLINGER ERIC C , CUSACK KEVIN P , HOBSON ADRIAN D , LI BIN , GORDON THOMAS D , STOFFEL ROBERT H , WALLACE GRIER A , GRONSGAARD PINTIPA , WANG LU
Inventor: BREINLINGER ERIC C , CUSACK KEVIN P , HOBSON ADRIAN D , LI BIN , GORDON THOMAS D , STOFFEL ROBERT H , WALLACE GRIER A , GRONSGAARD PINTIPA , WANG LU
IPC: C07D249/10 , A61K31/415 , A61K31/4196 , A61K31/42 , A61P35/00 , C07D231/14 , C07D261/14 , C07D403/12
CPC classification number: C07D249/10 , C07D231/14 , C07D249/06 , C07D261/14 , C07D261/18 , C07D273/02 , C07D333/36 , C07D333/38 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/04 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D413/04 , C07D413/10 , C07D413/12 , C07D413/14 , C07D417/12
Abstract: Disclosed herein are novel compounds of Formula (I), wherein the variables are defined as herein. The compounds of Formula (I) are useful as kinase inhibitors and as such would be useful in treating certain conditions and diseases, especially inflammatory conditions and diseases as well as proliferative disorders such as cancer.
Abstract translation: 本文公开了式(I)的新化合物,其中变量如本文所定义。 式(I)的化合物可用作激酶抑制剂,因此可用于治疗某些病症和疾病,特别是炎性疾病和疾病以及增殖性疾病如癌症。
-
公开(公告)号:WO2007117465A3
公开(公告)日:2008-08-28
申请号:PCT/US2007008307
申请日:2007-04-02
Applicant: ABBOTT LAB , ERICSSON ANNA M , BURCHAT ANDREW , FRANK KRISTINE E , CALDERWOOD DAVID J , ABBOTT LILY K , ARGIRIADI MARIA A , BORHANI DAVID W , CUSACK KEVIN P , DIXON RICHARD W , GORDON THOMAS D , MULLEN KELLY D , TALANIAN ROBERT V , WU XIAOYUN , ZHANG XIAOLEI , WANG LU X , LI BIQIN , BARBERIS CLAUDE E , WISHART NEIL
Inventor: ERICSSON ANNA M , BURCHAT ANDREW , FRANK KRISTINE E , CALDERWOOD DAVID J , ABBOTT LILY K , ARGIRIADI MARIA A , BORHANI DAVID W , CUSACK KEVIN P , DIXON RICHARD W , GORDON THOMAS D , MULLEN KELLY D , TALANIAN ROBERT V , WU XIAOYUN , ZHANG XIAOLEI , WANG LU X , LI BIQIN , BARBERIS CLAUDE E , WISHART NEIL
IPC: A61K31/5377
CPC classification number: C07D487/04 , C07D403/12 , C07D403/14 , C07D409/04 , C07D409/14
Abstract: Novel compounds of Formula (I) or pharmaceutically acceptable salts, prodrugs and biologically active metabolites thereof of Formula (I) wherein the substituents are as defined herein, which are useful as therapeutic agents.
Abstract translation: 式(I)的新型化合物或其药学上可接受的盐,前体药物和式(I)的生物活性代谢物,其中取代基如本文所定义,其可用作治疗剂。
-
公开(公告)号:EP1753428A4
公开(公告)日:2010-09-15
申请号:EP05778736
申请日:2005-05-13
Applicant: ABBOTT LAB
Inventor: CUSACK KEVIN , SALMERON-GARCIA JOSE-ANDRES , GORDON THOMAS D , BARBERIS CLAUDE E , ALLEN HAMISH J , BISCHOFF AGNIESZKA K , ERICSSON ANNA M , FRIEDMAN MICHAEL M , GEORGE DAWN M , ROTH GREGORY P , TALANIAN ROBERT V , THOMAS CHRISTINE , WALLACE GRIER A , WISHART NEIL , YU ZHENGTIAN
IPC: C07D471/02 , A61K31/4743 , C07D471/04 , C07D491/04 , C07D495/04 , C07D498/02
CPC classification number: C07D471/04 , A61K31/4743 , C07D487/04 , C07D491/04 , C07D495/04
Abstract: A compound or pharmaceutically acceptable salts thereof of Formula (I) wherein the substituents are as defined herein, which are useful as kinase inhibitors.
-
8.PROCESS FOR THE PREPARATION AND ISOLATION OF THE INDIVIDUAL STEREOISOMERS OF 1-AMINO, 3-SUBSTITUTED PHENYLCYCLOPENTANE CARBOXYLATES 审中-公开
Title translation: 用于产生和的每个异构体提取方法的1-氨基-3-取代PHENYLCYCLOPENTANCARBOXYLATEN公开(公告)号:EP2102145A4
公开(公告)日:2014-06-18
申请号:EP07863231
申请日:2007-12-21
Applicant: ABBOTT LAB
Inventor: GORDON THOMAS D , WALLACE GRIER A , HAYES MARTIN E , LUKIN KIRILL A , WANG LEI , FERNANDO DILINIE P
IPC: C07C45/69 , C07C49/697 , C07C49/753 , C07C227/18 , C07C227/24 , C07C227/26 , C07C227/34 , C07C229/48 , C07C253/00 , C07C253/34 , C07C255/46 , C07D235/02
CPC classification number: C07D235/02 , C07B2200/07 , C07C45/69 , C07C227/18 , C07C227/24 , C07C227/26 , C07C227/34 , C07C253/00 , C07C253/34 , C07C2601/08 , C07C49/697 , C07C49/753 , C07C229/48 , C07C255/46
-
公开(公告)号:UY33957A
公开(公告)日:2012-10-31
申请号:UY33957
申请日:2012-03-15
Applicant: ABBOTT LAB
Inventor: ERICSSON ANNA M , MICHAEL FRIEDMAN , MORYTKO MICHAEL J , CUSACK KEVIN P , GORDON THOMAS D , IHLE DAVID C , HAYES MARTIN E , BREINLINGER ERIC C , BIN LI , LEI WANG , MARTINEZ GLORIA Y , ANDREW BURCHAT , HOBSON ADRIAN D , MULLEN KELLY D
IPC: A61K31/047 , A61K31/122 , A61K31/357 , A61K31/416 , A61K31/44 , A61P43/00 , C07C39/23 , C07C49/513 , C07C49/747 , C07C49/755 , C07D213/75 , C07D223/18 , C07D231/54 , C07D317/72 , C07D401/12 , C07D491/10
Abstract: Un compuesto de fórmula I, sales, prodrogas, metabolitos biológicamente activos, estereoisómeros e isómeros farmacéuticamente aceptables del mismo, en donde las variables se definieron en la presente. Los compuestos de la invención son de utilidad para el tratamiento de condiciones inmunológicas y oncológicas.
-
公开(公告)号:MX2009006751A
公开(公告)日:2009-06-30
申请号:MX2009006751
申请日:2007-12-21
Applicant: ABBOTT LAB
Inventor: FIX-STENZEL SHANNON R , GORDON THOMAS D , WALLACE GRIER A , GRONGSAARD PINTIPA , CUSACK KEVIN P , HOBSON ADRIAN D , BREINLINGER ERIC C , ANSELL GRAHAM K , HAYES MARTIN E
IPC: A01N43/50 , A61K31/415
Abstract: La presente invención se dirige a agentes novedosos, potentes y selectivos, los cuales son agonistas o antagonistas del uno omás de los receptores individuales de la familia del receptor S1P. Los compuestos de la presente invención son útiles como terapéuticos para tratar condiciones médicas asociadas con agonismo o antagonismo de los receptores individuales de la familia del receptor S1P.
-
-
-
-
-
-
-
-
-